[Kallmann syndrome]

Nihon Rinsho. 2006 Jun 28:Suppl 2:220-4.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Chorionic Gonadotropin / administration & dosage
  • Diagnosis, Differential
  • Estrogens / administration & dosage
  • Extracellular Matrix Proteins / genetics
  • Female
  • Gonadotropin-Releasing Hormone / administration & dosage
  • Humans
  • Kallmann Syndrome* / diagnosis
  • Kallmann Syndrome* / genetics
  • Kallmann Syndrome* / physiopathology
  • Kallmann Syndrome* / therapy
  • Male
  • Menotropins / administration & dosage
  • Mutation
  • Nerve Tissue Proteins / genetics
  • Prognosis
  • Receptor, Fibroblast Growth Factor, Type 1 / genetics
  • Testosterone / administration & dosage

Substances

  • ANOS1 protein, human
  • Chorionic Gonadotropin
  • Estrogens
  • Extracellular Matrix Proteins
  • Nerve Tissue Proteins
  • Gonadotropin-Releasing Hormone
  • Testosterone
  • Menotropins
  • FGFR1 protein, human
  • Receptor, Fibroblast Growth Factor, Type 1